First Edition: Thursday, May 14, 2026
Today's early morning highlights from the major news organizations.
Archives: Morning Breakouts
161 - 180 of 112,363 Results
-
-
Viewpoints: Kennedy’s Misguided Push Against Antidepressants; Why Do We Keep Getting Virus Spread Wrong?
Opinion writers examine these public health issues.
By khnelysiag -
A Drug’s Rocky Road To Discovery May Signal Pancreatic Cancer Breakthrough
The New York Times reports on daraxonrasib, the first drug to substantially extend the lives of patients with pancreatic cancer. The cellular proteins it targets fuel the three leading causes of cancer deaths: pancreatic tumors, lung, and colon cancers. The drug is fast-tracked for review by the Food and Drug Administration and could win approval later this year.
-
Federal Criminal Probe Over New York Hospital’s Gender-Affirming Care Escalates
According to The 19th, the federal government wants access to the medical records of children who have received gender-affirming care over the past six years. Also: Some states are trying to roll back disability rights; 25,000 UC Health workers are set to strike; and more.
-
Study: Millions Of Children Can Access Loaded, Unsecured Guns At Home
A recent JAMA study reveals that nearly 7 million U.S. children live in homes with at least one loaded, unlocked gun. Also in the news: suicide, the yo-yo diet effect, testosterone, and more.
-
Healthcare Providers Demand Stricter Rules For Medical Record Sharing
Hundreds of thousands of patients' records from health systems across the country have been compromised, The Washington Post reports. This underscores the necessity for health IT officials and executives to close security gaps in the electronic network used to transfer medical records between hospitals, physicians’ offices, and laboratories.
-
FDA Head Makary Resigns; Top Food Official Diamantas Stepping In
Politico reports that Marty Makary’s time leading the FDA saw mass layoffs, ongoing churn among senior leaders, and policy fights. Meanwhile, Fox News reports that the FDA has approved the first-ever non-antipsychotic drug treatment for agitation in Alzheimer’s disease patients.
-
Hantavirus Infects 11 Across The Globe As WHO Warns More Will Fall Ill
Minnesota is monitoring a resident who might have been exposed to the virus by a passenger of the MV Hondius, while Illinois health officials are investigating a potential case that they don't think is related to the cruise ship outbreak. Meanwhile, a mishmash of strategies to stop the spread is complicating the global response to the outbreak.
-
First Edition: Wednesday, May 13, 2026
Today's early morning highlights from the major news organizations.
By khnkit -
Viewpoints: Life Before The Measles Vaccine; Cruise Ship Outbreak Proves We Learned Nothing From Covid
Editorial writers discuss these public health topics.
By khnelysiag -
Wearables Using AI To Predict Future Health Events
The makers of these heath trackers hope to incorporate AI to predict future ailments such as heart attack, stroke, and dementia, Bloomberg reports. Also: GLP-1s might reduce risk of macular degeneration; NAD+ supplement use is booming; and more.
-
Coalition For Health AI Suggests Safeguards On AI Use In Medicaid Programs
Some states are contemplating the use of AI to determine eligibility of Medicaid work requirements under President Donald Trump’s tax law. More than 40 health organizations have participated in the feedback process to establish CHAI's proposed standards and guardrails for AI use, Modern Healthcare reports.
-
White House: Trump Is Scheduled For A Medical Exam This Month
President Donald Trump will head to Walter Reed National Military Medical Center on May 26, the AP reports, for what the White House says is an annual physical and regular preventive care. Also in the news: vaccines, FDA leadership, and fruit-flavored vapes.
-
AMA Guides Doctors On How To Protect Against AI Deepfakes
Fierce Healthcare reports on the American Medical Association's new framework for doctor identity protections. Also in public health news: alcohol addiction, suicide prevention, tick bites, and more.
-
Justice Alito Extends Supreme Court’s Deadline For Mifepristone Ruling
The court has until Thursday to determine the legality of telemedicine access to the abortion pill mifepristone. In the meantime, mifepristone may still be prescribed online and distributed by mail, NPR reports. Also in the news: fertility treatment coverage rules; PCOS' renaming; and more.
-
US Hantavirus Cruisegoer Is Moved To Atlanta After Showing Symptoms
MedPage Today reports on the relocation of the American passenger and their partner from quarantine at the University of Nebraska Medical Center in Omaha to Emory University in Atlanta after the person developed symptoms. The Trump administration's response to the virus and the search for treatments are also in the news.
-
First Edition: Tuesday, May 12, 2026
Today's early morning highlights from the major news organizations.
By khnkit -
Viewpoints: Can GLP-1s Trigger Eating Disorders In Older Adults?; RFK Jr. Vs. Hospital Jell-O
Opinion writers discuss these public health topics.
By khnelysiag -
Pediatricians Say Recess Is Vital To Students’ Health And Academic Success
New guidance from the American Academy of Pediatrics touts the physical, emotional, and academic benefits of recess for kids of all ages, the AP reports. The group also recommends that recess should not only be protected but also not withheld for academic or punitive reasons, as sometimes happens.
By khnlaureno -
Medicare Spending, Uptake Remain Low For New Alzheimer’s Drugs
STAT reports how Leqembi and Kisunla, the recently approved Alzheimer's drugs, have had low uptake from those in need due to how hard they are to administer and their potential for severe side effects like brain bleeding. Also in the news: a pacemaker recall; a new cancer treatment; miniature therapy horses; and more.
By khnlaureno